Showing results (541-550 of 7,984) with videos related to
Sort By:
Pageof 799
Current Medicinal Chemistry|May 12, 2004
New developments on thromboxane and prostacyclin modulators part I: thromboxane modulatorsJean-Michel Dogné, Xavier de Leval, Julien Hanson, et al.Current Medicinal Chemistry|May 12, 2004
Biological activity and delivery of peptide nucleic acids (PNA)-DNA chimeras for transcription factor decoy (TFD) pharmacotherapyRoberto GambariCurrent Medicinal Chemistry|May 12, 2004
Mitochondrial superoxide dismutase: a promising target for new anticancer therapiesGiovambattista Pani, Renata Colavitti, Barbara Bedogni, et al.Current Medicinal Chemistry|May 12, 2004
Proanthocyanidins in health care: current and new trendsP Cos, T De Bruyne, N Hermans, et al.Current Medicinal Chemistry|August 27, 2022
Nutraceuticals in the Treatment of Inflammatory Bowel Disease: How the Panorama has Changed in the Last Decade?Antonella Smeriglio, Daniele Marcoccia, Marcella Denaro, et al.Current Medicinal Chemistry|September 9, 2022
Immunometabolism Dysfunction in the Pathophysiology and Treatment of Rheumatoid ArthritisMaryam Masoumi, Nader Hashemi, Fatemeh Moadab, et al.Current Medicinal Chemistry|September 9, 2022
The Resilience of Pseudomonas aeruginosa to Antibiotics and the Designing of Antimicrobial Peptides to Overcome Microbial ResistanceDaniel Juárez-López, Estefanía Morales-Ruiz, Leonardo D Herrera-Zúñiga, et al.Current Medicinal Chemistry|September 6, 2022
An Overview of Thrombin Inhibitors in the Perspective of Structureactivity RelationshipsJiangming Wang, Xiaojing Sun, Na Li, et al.Current Medicinal Chemistry|September 6, 2022
Neuroprotective Properties of Ferulic Acid in Preclinical Models of Alzheimer's Disease: A Systematic Literature ReviewSiyu Zhou, Xiaoyu DongCurrent Medicinal Chemistry|September 6, 2022
Putative Therapeutic Impact of Inflammasome Inhibitors against COVID-19-Induced ARDSSeyed Fazel Nabavi, Adeleh Sahebnasagh, Ahad Shahbazi, et al.Pageof 799